Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
•
Rheumatology
•
Discoid lupus
Is it safe to give radiation to a breast cancer patient with discoid lupus?
The patient has notable lip lesions from her discoid lupus erythematosus
Answer from: Radiation Oncologist at Community Practice
In published data with whole breast, it is well tolerated and we don’t consider this as a contraindication to BCT.
Sign in or Register to read more
15099
Related Questions
When treating chestwall + RNI with VMAT, how much do you crop the PTV into lung as is done with the PTVeval in 3D contouring guides?
What is the earliest you would start postmastectomy radiation after adjuvant chemotherapy for a patient with breast cancer?
How would you treat a young breast cancer patient with limited nodal involvement and an isolated sternal oligometastasis at diagnosis?
How do you approach boost to the lumpectomy cavity AND 4 lymph nodes with extra-nodal extension when treating breast cancer with hypofractionation?
Have the breast surgeons at your institution adopted the SOUND trial into their clinical practice?
How do the results of INSEMA and SOUND impact the decision of omitting SLND in young women with breast cancer and offering adjuvant RT to patients who would otherwise be candidates for omission?
In a patient with T2N0 breast cancer with skin involvement s/p lumpectomy and negative margins, if you are offering whole breast radiation, would you bolus your tangent fields?
Is 5fx APBI and no endocrine therapy a new standard of care for women over 70 years old with low-risk breast cancer given the interim analysis of the EUROPA trial?
Would you consider partial breast irradiation in patients who otherwise meet PBI guidelines who have a pathogenic variant of CHEK2 or other moderate penetrance gene?
Does radiation therapy (ex. to the breast) in patients with CDK4 mutations increase the risk of developing melanoma?